![]() |
市場調查報告書
商品編碼
1876148
嬰兒配方奶粉原料及產品市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察與預測(2024-2032 年)Infant Formula Ingredients and Products Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
受嬰兒營養意識的提高、女性勞動參與率的上升以及配方奶粉配方技術進步的推動,全球嬰兒配方奶粉原料及產品市場持續穩步增長。根據 Fortune Business Insights 預測,該市場規模預計將在 2024 年達到 749.4 億美元,並在 2025 年達到 776.4 億美元。預計到 2032 年,該市場將進一步成長至 1,097 億美元,在預測期(2025-2032 年)內,複合年增長率 (CAGR) 為 5.06%。亞太地區將在 2024 年引領全球市場,佔 66.2% 的市場佔有率,市場估值達 496.1 億美元。這反映了該地區強大的消費群體以及人們對嬰幼兒健康和保健日益增長的關注。
嬰兒配方奶粉旨在取代母乳,透過蛋白質、碳水化合物、脂肪、維生素和礦物質等關鍵成分提供均衡營養。這些配方奶粉通常以牛奶為基礎,但也可用大豆、羊奶和其他植物性成分製成。雀巢、雅培、達能和利潔時集團等全球性公司推動著這個市場的發展,它們不斷推出先進產品,以滿足具有不同飲食和醫療需求的嬰幼兒。
市場動態
市場推動因素-父母意識的提高與對特殊嬰兒配方奶粉需求的成長
父母對嬰幼兒營養重要性的認識不斷提高,顯著推動了對與母乳成分高度相似的科學配方產品的需求。在亞洲、中東和北美,越來越注重健康的父母正在尋找富含人乳低聚醣 (HMO)、益生元和乳鐵蛋白的配方奶粉,以支持嬰兒的免疫和消化健康。
對特殊嬰兒配方奶粉的需求是另一個主要的成長因素。隨著嬰兒乳糖不耐症和食物過敏的盛行率不斷上升,製造商正在推出創新的無乳糖、低過敏性和植物性產品。例如,2024 年 9 月,Perrigo 與 Dr. Brown's 和 GoodStart 合作推出了一款 100% 植物性、無乳糖的嬰兒配方奶粉,該產品在美國主要零售商(如沃爾瑪、克羅格和亞馬遜)有售。這些專業解決方案為過敏和不耐受的嬰兒提供支持,推動了全球市場的擴張。
市場阻礙因素-高昂的製造成本和原物料價格波動
儘管需求強勁,但採購優質嬰兒配方奶粉原料(例如奶粉、植物油和維生素)的高昂製造成本構成了一項重大挑戰。價格波動,尤其是有機原料和特殊原料的價格波動,以及供應鏈中斷和能源成本上漲,都在影響生產利潤率。
市場機會-配方奶粉研發的技術創新
技術進步正在為市場擴張開闢新的途徑。先進的生產技術,例如微濾、超臨界流體萃取和基於發酵的合成,使得生產更接近母乳特性的原料成為可能。例如,2020年4月,康納根公司(Conagen Inc.)利用發酵技術開發出乳鐵蛋白,這是一種對嬰兒免疫力至關重要的蛋白質,從而減少了對傳統乳製品原料的依賴,並降低了生產成本。
市場趨勢
消費者對模擬母乳成分的新偏好
消費者越來越傾向於選擇添加了模擬母乳營養結構的成分的嬰兒配方奶粉。諸如OPO(結構性脂質)、HMO和A2 β-酪蛋白等成分正受到越來越多的關注,尤其是在中國、印度和東南亞地區。 2023年10月,國際香料香精公司(IFF)、帝斯曼-菲美尼克公司和蒙牛公司在中國獲得監管部門批准,可在嬰兒配方奶粉生產中使用HMO和益生菌,這標誌著嬰兒配方奶粉正朝著高品質、生物活性更高的配方方向發展。
依成分類型劃分:
2024年,碳水化合物作為嬰兒的主要能量來源,佔了全球嬰兒配方奶粉成分市場的最大佔有率。乳糖是大多數嬰兒配方奶粉的必要成分,因為它有助於大腦發育和營養吸收。脂肪佔嬰兒熱量攝取的40-45%,並促進神經系統發育,佔了第二大佔有率。蛋白質對組織生長和修復至關重要,佔了第三大佔有率。益生元和益生菌區隔市場預計將在2032年之前實現最快成長,這得益於針對腸道健康和免疫健康的持續創新。
依產品類型劃分:
2024年,針對特定營養需求(例如過敏、代謝紊亂和早產兒營養)的特製嬰兒配方奶粉區隔市場引領市場。由於其成分與天然母乳相似,且對嬰兒的免疫系統和消化系統有益,富含人乳低聚醣(HMO)的嬰兒配方奶粉是增長最快的品類。 2023年3月,達能公司在美國推出了Pepticate,這是一款專為牛奶蛋白過敏嬰兒設計的低致敏性水解配方奶粉。
亞太地區 - 2024年主要市場
亞太地區預計將主導市場,到2024年市場規模將達到496.1億美元,這主要得益於女性勞動參與率的提高、快速的城市化進程以及中產階級的壯大。中國、印度和印尼等國家對高品質的專業嬰幼兒營養產品需求強勁。中國的二孩政策改革也刺激了出生率的上升,並增加了產品消費。據世界銀行稱,女性勞動參與率的提高可使該地區的GDP成長51%,間接推動嬰兒配方奶粉市場的發展。
北美:
繼2022年美國嬰兒配方奶粉短缺之後,製造商正在加強本地供應鏈並制定安全法規,以確保產品供應穩定。國內生產和政府乾預繼續支持該地區的復甦和供應穩定。
歐洲:
歐洲消費者強烈偏好有機和無添加劑的嬰兒配方奶粉,基於母乳寡糖 (HMO) 和 A2 蛋白的產品越來越受歡迎。針對乳糖不耐症和過敏管理的優質產品正在推動該地區的穩定成長。
南美洲:
該地區穩定的出生率和不斷增長的可支配收入正在推動對功能性植物基大豆嬰兒配方奶粉的需求。巴西和阿根廷的製造商正在以 "支持骨骼健康" 和 "溫和不刺激腸胃" 等宣傳語來定位其產品,以吸引註重健康的父母。
中東和非洲:
不斷增長的外籍人口和對優質進口嬰兒配方奶粉的需求正在推動市場擴張,尤其是在阿拉伯聯合大公國和沙烏地阿拉伯。
The global infant formula ingredients and products market continues to grow steadily, driven by increasing awareness of infant nutrition, rising female workforce participation, and technological advancements in formula composition. According to Fortune Business Insights, the market was valued at USD 74.94 billion in 2024, is projected to reach USD 77.64 billion in 2025, and is estimated to expand to USD 109.70 billion by 2032, reflecting a CAGR of 5.06% during the forecast period (2025-2032). Asia Pacific dominated the global landscape in 2024, accounting for 66.2% of the market share, with a valuation of USD 49.61 billion, underscoring the region's strong consumer base and growing focus on infant health and wellness.
Infant formula products are designed to serve as alternatives to breast milk, providing balanced nutrition through key ingredients such as proteins, carbohydrates, fats, vitamins, and minerals. These formulas are often derived from cow's milk but can also be sourced from soy, goat milk, and other plant-based materials. The market is being driven by global players like Nestle S.A., Abbott, Danone S.A., and Reckitt Benckiser Group plc, who continue to introduce advanced products catering to infants with diverse dietary and medical needs.
Market Dynamics
Market Drivers - Growing Parental Awareness and Demand for Specialized Formulas
Rising parental awareness about the importance of infant nutrition has significantly fueled the demand for scientifically formulated products that closely resemble human milk. Increasingly health-conscious parents in Asia, the Middle East, and North America are seeking formulas enriched with HMOs (Human Milk Oligosaccharides), prebiotics, and Lactoferrin, which support immunity and digestive health.
The demand for specialty infant formulas is another key growth driver. As the prevalence of lactose intolerance and food allergies among infants rises, manufacturers are launching innovative lactose-free, hypoallergenic, and plant-based products. For instance, in September 2024, Perrigo Company plc partnered with Dr. Brown's Company and Good Start to introduce a 100% plant-based, lactose-free infant formula available through major U.S. retailers such as Walmart, Kroger, and Amazon. These specialized solutions help infants with allergies or sensitivities, supporting market expansion worldwide.
Market Restraints - High Production Costs and Ingredient Price Volatility
Despite strong demand, the high manufacturing costs of infant formula ingredients-driven by the procurement of high-quality milk powder, vegetable oils, and vitamins-pose a significant challenge. Price fluctuations in raw materials, especially organic and specialty components, combined with supply chain disruptions and energy cost increases, have impacted production margins.
Market Opportunities - Technological Innovations in Formula Development
Technological advancements have opened new avenues for market expansion. Cutting-edge production techniques such as microfiltration, supercritical fluid extraction, and fermentation-based synthesis are enabling the creation of ingredients that mimic human milk properties more closely than ever before. For example, in April 2020, Conagen Inc. developed Lactoferrin-a key protein for infant immunity-using fermentation technology, reducing dependence on traditional dairy sources and lowering production costs.
Market Trends
Emerging Preference for Human-Milk-Mimicking Ingredients
Consumers increasingly favor infant formulas enriched with components that replicate the nutritional structure of human milk. Ingredients such as OPO (Structured Lipids), HMOs, and A2 B-casein proteins are gaining traction, particularly in China, India, and Southeast Asia. In October 2023, International Flavors & Fragrances (IFF), DSM-Firmenich, and Mengniu received regulatory approval to use HMOs and probiotics in infant formula production in China, signaling a shift toward premium, biologically advanced formulations.
By Ingredient Type:
In 2024, carbohydrates held the largest share of the global infant formula ingredients market, as they serve as the primary energy source for infants. Lactose supports brain development and nutrient absorption, making it an essential component in most formulas. Fats accounted for the second-largest share, contributing 40-45% of infants' caloric intake and promoting nervous system development. Proteins, crucial for tissue growth and repair, held the third-largest share. The prebiotics and probiotics segment is projected to grow the fastest through 2032, supported by ongoing innovations targeting gut and immune health.
By Product Type:
The specialty formula segment dominated the market in 2024, addressing specific dietary needs such as allergies, metabolic disorders, and premature birth nutrition. The HMO-enriched formula segment represents the fastest-growing category, driven by its similarity to natural breast milk composition and its ability to enhance infants' immune and digestive systems. In March 2023, Danone launched Pepticate, a hypoallergenic hydrolyzed powdered formula in the U.S., to cater to infants with cow's milk allergies.
Asia Pacific - The Leading Market in 2024
Asia Pacific held the dominant share with a market value of USD 49.61 billion in 2024, driven by increasing female workforce participation, rapid urbanization, and expanding middle-class populations. Countries such as China, India, and Indonesia are witnessing a strong demand for premium and specialized infant nutrition products. The Chinese government's two-child policy reform has also stimulated birth rates, leading to higher product consumption. According to the World Bank, increasing women's workforce participation could enhance the region's GDP by 51%, indirectly boosting the infant formula market.
North America:
Following the 2022 infant formula shortage in the U.S., manufacturers are strengthening local supply chains and safety regulations to ensure product stability. Domestic production and government intervention continue to shape the region's recovery and supply consistency.
Europe:
European consumers show a strong inclination toward organic and additive-free formulas, with growing adoption of HMO- and A2-protein-based products. Premium offerings targeting lactose intolerance and allergy management are driving steady regional growth.
South America:
The region's stable birth rates and rising disposable incomes are fueling demand for functional, plant-based soy formulas. Manufacturers in Brazil and Argentina are focusing on positioning their products with claims such as "supports bone health" and "gentle on the stomach" to attract health-conscious parents.
Middle East & Africa:
The increasing expatriate population and demand for premium imported infant formulas are contributing to market expansion, especially in the United Arab Emirates and Saudi Arabia.
Competitive Landscape
The market features strong competition among leading companies such as Nestle S.A. (Switzerland), Abbott (U.S.), Danone S.A. (France), Reckitt Benckiser Group plc (U.K.), and Junlebao Dairy Group (China). Other notable players include Fonterra Co-operative Group Limited, DSM-Firmenich, Cargill, Inc., Almarai, and FrieslandCampina N.V.
Recent Industry Developments:
Conclusion
The global infant formula ingredients and products market is set to expand from USD 74.94 billion in 2024 to USD 109.70 billion by 2032, reflecting sustained growth across all regions. Rising consumer awareness, technological innovation, and premiumization trends are reshaping the infant nutrition industry. With Asia Pacific leading the charge and Western markets focusing on safety, sustainability, and advanced formulations, the sector is poised to achieve strong, innovation-driven growth throughout the 2025-2032 period.
Segmentation By Ingredient Type
By Product Type
By Region